0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antiparasitic Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2A6243
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antiparasitic Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Antiparasitic Drugs Market Research Report 2025

Code: QYRE-Auto-2A6243
Report
July 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antiparasitic Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antiparasitic Drugs Market

Antiparasitic Drugs Market

The global market for Antiparasitic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiparasitic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiparasitic Drugs.
The Antiparasitic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiparasitic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiparasitic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antiparasitic Drugs Market Report

Report Metric Details
Report Name Antiparasitic Drugs Market
CAGR 5%
by Type
  • by Delivery Type
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ipca Laboratories Ltd, Zydus Cadila, Merck, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Roche Inc, Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca, Alkem Laboratories Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antiparasitic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antiparasitic Drugs Market report?

Ans: The main players in the Antiparasitic Drugs Market are Ipca Laboratories Ltd, Zydus Cadila, Merck, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Roche Inc, Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca, Alkem Laboratories Limited

What are the Application segmentation covered in the Antiparasitic Drugs Market report?

Ans: The Applications covered in the Antiparasitic Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Antiparasitic Drugs Market report?

Ans: The Types covered in the Antiparasitic Drugs Market report are by Delivery Type

Recommended Reports

Infectious Disease Drugs

Pharmaceutical Market Services

Specialized Drug Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiparasitic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 by Type
1.2.3 by Delivery Type
1.3 Market by Application
1.3.1 Global Antiparasitic Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiparasitic Drugs Market Perspective (2020-2031)
2.2 Global Antiparasitic Drugs Growth Trends by Region
2.2.1 Global Antiparasitic Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antiparasitic Drugs Historic Market Size by Region (2020-2025)
2.2.3 Antiparasitic Drugs Forecasted Market Size by Region (2026-2031)
2.3 Antiparasitic Drugs Market Dynamics
2.3.1 Antiparasitic Drugs Industry Trends
2.3.2 Antiparasitic Drugs Market Drivers
2.3.3 Antiparasitic Drugs Market Challenges
2.3.4 Antiparasitic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiparasitic Drugs Players by Revenue
3.1.1 Global Top Antiparasitic Drugs Players by Revenue (2020-2025)
3.1.2 Global Antiparasitic Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antiparasitic Drugs Revenue
3.4 Global Antiparasitic Drugs Market Concentration Ratio
3.4.1 Global Antiparasitic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiparasitic Drugs Revenue in 2024
3.5 Global Key Players of Antiparasitic Drugs Head office and Area Served
3.6 Global Key Players of Antiparasitic Drugs, Product and Application
3.7 Global Key Players of Antiparasitic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiparasitic Drugs Breakdown Data by Type
4.1 Global Antiparasitic Drugs Historic Market Size by Type (2020-2025)
4.2 Global Antiparasitic Drugs Forecasted Market Size by Type (2026-2031)
5 Antiparasitic Drugs Breakdown Data by Application
5.1 Global Antiparasitic Drugs Historic Market Size by Application (2020-2025)
5.2 Global Antiparasitic Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antiparasitic Drugs Market Size (2020-2031)
6.2 North America Antiparasitic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antiparasitic Drugs Market Size by Country (2020-2025)
6.4 North America Antiparasitic Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiparasitic Drugs Market Size (2020-2031)
7.2 Europe Antiparasitic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antiparasitic Drugs Market Size by Country (2020-2025)
7.4 Europe Antiparasitic Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiparasitic Drugs Market Size (2020-2031)
8.2 Asia-Pacific Antiparasitic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antiparasitic Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Antiparasitic Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiparasitic Drugs Market Size (2020-2031)
9.2 Latin America Antiparasitic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antiparasitic Drugs Market Size by Country (2020-2025)
9.4 Latin America Antiparasitic Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiparasitic Drugs Market Size (2020-2031)
10.2 Middle East & Africa Antiparasitic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antiparasitic Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Antiparasitic Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ipca Laboratories Ltd
11.1.1 Ipca Laboratories Ltd Company Details
11.1.2 Ipca Laboratories Ltd Business Overview
11.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Introduction
11.1.4 Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2020-2025)
11.1.5 Ipca Laboratories Ltd Recent Development
11.2 Zydus Cadila
11.2.1 Zydus Cadila Company Details
11.2.2 Zydus Cadila Business Overview
11.2.3 Zydus Cadila Antiparasitic Drugs Introduction
11.2.4 Zydus Cadila Revenue in Antiparasitic Drugs Business (2020-2025)
11.2.5 Zydus Cadila Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Antiparasitic Drugs Introduction
11.3.4 Merck Revenue in Antiparasitic Drugs Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Antiparasitic Drugs Introduction
11.4.4 Pfizer Revenue in Antiparasitic Drugs Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline Plc.
11.5.1 GlaxoSmithKline Plc. Company Details
11.5.2 GlaxoSmithKline Plc. Business Overview
11.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Introduction
11.5.4 GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2020-2025)
11.5.5 GlaxoSmithKline Plc. Recent Development
11.6 Cipla Ltd
11.6.1 Cipla Ltd Company Details
11.6.2 Cipla Ltd Business Overview
11.6.3 Cipla Ltd Antiparasitic Drugs Introduction
11.6.4 Cipla Ltd Revenue in Antiparasitic Drugs Business (2020-2025)
11.6.5 Cipla Ltd Recent Development
11.7 Ranbaxy Laboratories
11.7.1 Ranbaxy Laboratories Company Details
11.7.2 Ranbaxy Laboratories Business Overview
11.7.3 Ranbaxy Laboratories Antiparasitic Drugs Introduction
11.7.4 Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2020-2025)
11.7.5 Ranbaxy Laboratories Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Antiparasitic Drugs Introduction
11.8.4 Novartis AG Revenue in Antiparasitic Drugs Business (2020-2025)
11.8.5 Novartis AG Recent Development
11.9 Alvizia Health Care
11.9.1 Alvizia Health Care Company Details
11.9.2 Alvizia Health Care Business Overview
11.9.3 Alvizia Health Care Antiparasitic Drugs Introduction
11.9.4 Alvizia Health Care Revenue in Antiparasitic Drugs Business (2020-2025)
11.9.5 Alvizia Health Care Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Antiparasitic Drugs Introduction
11.10.4 Bayer AG Revenue in Antiparasitic Drugs Business (2020-2025)
11.10.5 Bayer AG Recent Development
11.11 Roche Inc
11.11.1 Roche Inc Company Details
11.11.2 Roche Inc Business Overview
11.11.3 Roche Inc Antiparasitic Drugs Introduction
11.11.4 Roche Inc Revenue in Antiparasitic Drugs Business (2020-2025)
11.11.5 Roche Inc Recent Development
11.12 Arbor Pharmaceuticals Inc.
11.12.1 Arbor Pharmaceuticals Inc. Company Details
11.12.2 Arbor Pharmaceuticals Inc. Business Overview
11.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Introduction
11.12.4 Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2020-2025)
11.12.5 Arbor Pharmaceuticals Inc. Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Antiparasitic Drugs Introduction
11.13.4 Sanofi Revenue in Antiparasitic Drugs Business (2020-2025)
11.13.5 Sanofi Recent Development
11.14 AstraZeneca
11.14.1 AstraZeneca Company Details
11.14.2 AstraZeneca Business Overview
11.14.3 AstraZeneca Antiparasitic Drugs Introduction
11.14.4 AstraZeneca Revenue in Antiparasitic Drugs Business (2020-2025)
11.14.5 AstraZeneca Recent Development
11.15 Alkem Laboratories Limited
11.15.1 Alkem Laboratories Limited Company Details
11.15.2 Alkem Laboratories Limited Business Overview
11.15.3 Alkem Laboratories Limited Antiparasitic Drugs Introduction
11.15.4 Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2020-2025)
11.15.5 Alkem Laboratories Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Antiparasitic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of by Type
 Table 3. Key Players of by Delivery Type
 Table 4. Global Antiparasitic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Antiparasitic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Antiparasitic Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Antiparasitic Drugs Market Share by Region (2020-2025)
 Table 8. Global Antiparasitic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Antiparasitic Drugs Market Share by Region (2026-2031)
 Table 10. Antiparasitic Drugs Market Trends
 Table 11. Antiparasitic Drugs Market Drivers
 Table 12. Antiparasitic Drugs Market Challenges
 Table 13. Antiparasitic Drugs Market Restraints
 Table 14. Global Antiparasitic Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Antiparasitic Drugs Market Share by Players (2020-2025)
 Table 16. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiparasitic Drugs as of 2024)
 Table 17. Ranking of Global Top Antiparasitic Drugs Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Antiparasitic Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Antiparasitic Drugs, Headquarters and Area Served
 Table 20. Global Key Players of Antiparasitic Drugs, Product and Application
 Table 21. Global Key Players of Antiparasitic Drugs, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Antiparasitic Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Antiparasitic Drugs Revenue Market Share by Type (2020-2025)
 Table 25. Global Antiparasitic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Antiparasitic Drugs Revenue Market Share by Type (2026-2031)
 Table 27. Global Antiparasitic Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Antiparasitic Drugs Revenue Market Share by Application (2020-2025)
 Table 29. Global Antiparasitic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Antiparasitic Drugs Revenue Market Share by Application (2026-2031)
 Table 31. North America Antiparasitic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Antiparasitic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Antiparasitic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Antiparasitic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Antiparasitic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Antiparasitic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Antiparasitic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Antiparasitic Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Antiparasitic Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antiparasitic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Antiparasitic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Antiparasitic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Antiparasitic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Antiparasitic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Antiparasitic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Ipca Laboratories Ltd Company Details
 Table 47. Ipca Laboratories Ltd Business Overview
 Table 48. Ipca Laboratories Ltd Antiparasitic Drugs Product
 Table 49. Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 50. Ipca Laboratories Ltd Recent Development
 Table 51. Zydus Cadila Company Details
 Table 52. Zydus Cadila Business Overview
 Table 53. Zydus Cadila Antiparasitic Drugs Product
 Table 54. Zydus Cadila Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 55. Zydus Cadila Recent Development
 Table 56. Merck Company Details
 Table 57. Merck Business Overview
 Table 58. Merck Antiparasitic Drugs Product
 Table 59. Merck Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 60. Merck Recent Development
 Table 61. Pfizer Company Details
 Table 62. Pfizer Business Overview
 Table 63. Pfizer Antiparasitic Drugs Product
 Table 64. Pfizer Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 65. Pfizer Recent Development
 Table 66. GlaxoSmithKline Plc. Company Details
 Table 67. GlaxoSmithKline Plc. Business Overview
 Table 68. GlaxoSmithKline Plc. Antiparasitic Drugs Product
 Table 69. GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 70. GlaxoSmithKline Plc. Recent Development
 Table 71. Cipla Ltd Company Details
 Table 72. Cipla Ltd Business Overview
 Table 73. Cipla Ltd Antiparasitic Drugs Product
 Table 74. Cipla Ltd Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 75. Cipla Ltd Recent Development
 Table 76. Ranbaxy Laboratories Company Details
 Table 77. Ranbaxy Laboratories Business Overview
 Table 78. Ranbaxy Laboratories Antiparasitic Drugs Product
 Table 79. Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 80. Ranbaxy Laboratories Recent Development
 Table 81. Novartis AG Company Details
 Table 82. Novartis AG Business Overview
 Table 83. Novartis AG Antiparasitic Drugs Product
 Table 84. Novartis AG Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 85. Novartis AG Recent Development
 Table 86. Alvizia Health Care Company Details
 Table 87. Alvizia Health Care Business Overview
 Table 88. Alvizia Health Care Antiparasitic Drugs Product
 Table 89. Alvizia Health Care Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 90. Alvizia Health Care Recent Development
 Table 91. Bayer AG Company Details
 Table 92. Bayer AG Business Overview
 Table 93. Bayer AG Antiparasitic Drugs Product
 Table 94. Bayer AG Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 95. Bayer AG Recent Development
 Table 96. Roche Inc Company Details
 Table 97. Roche Inc Business Overview
 Table 98. Roche Inc Antiparasitic Drugs Product
 Table 99. Roche Inc Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 100. Roche Inc Recent Development
 Table 101. Arbor Pharmaceuticals Inc. Company Details
 Table 102. Arbor Pharmaceuticals Inc. Business Overview
 Table 103. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product
 Table 104. Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 105. Arbor Pharmaceuticals Inc. Recent Development
 Table 106. Sanofi Company Details
 Table 107. Sanofi Business Overview
 Table 108. Sanofi Antiparasitic Drugs Product
 Table 109. Sanofi Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 110. Sanofi Recent Development
 Table 111. AstraZeneca Company Details
 Table 112. AstraZeneca Business Overview
 Table 113. AstraZeneca Antiparasitic Drugs Product
 Table 114. AstraZeneca Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 115. AstraZeneca Recent Development
 Table 116. Alkem Laboratories Limited Company Details
 Table 117. Alkem Laboratories Limited Business Overview
 Table 118. Alkem Laboratories Limited Antiparasitic Drugs Product
 Table 119. Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2020-2025) & (US$ Million)
 Table 120. Alkem Laboratories Limited Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Antiparasitic Drugs Picture
 Figure 2. Global Antiparasitic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antiparasitic Drugs Market Share by Type: 2024 VS 2031
 Figure 4. by Type Features
 Figure 5. by Delivery Type Features
 Figure 6. Global Antiparasitic Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Antiparasitic Drugs Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Others Case Studies
 Figure 11. Antiparasitic Drugs Report Years Considered
 Figure 12. Global Antiparasitic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Antiparasitic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Antiparasitic Drugs Market Share by Region: 2024 VS 2031
 Figure 15. Global Antiparasitic Drugs Market Share by Players in 2024
 Figure 16. Global Top Antiparasitic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiparasitic Drugs as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Antiparasitic Drugs Revenue in 2024
 Figure 18. North America Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Antiparasitic Drugs Market Share by Country (2020-2031)
 Figure 20. United States Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Antiparasitic Drugs Market Share by Country (2020-2031)
 Figure 24. Germany Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Antiparasitic Drugs Market Share by Region (2020-2031)
 Figure 32. China Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Antiparasitic Drugs Market Share by Country (2020-2031)
 Figure 40. Mexico Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Antiparasitic Drugs Market Share by Country (2020-2031)
 Figure 44. Turkey Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Antiparasitic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Ipca Laboratories Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 48. Zydus Cadila Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 49. Merck Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 50. Pfizer Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 51. GlaxoSmithKline Plc. Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 52. Cipla Ltd Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 53. Ranbaxy Laboratories Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 54. Novartis AG Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 55. Alvizia Health Care Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 56. Bayer AG Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 57. Roche Inc Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 58. Arbor Pharmaceuticals Inc. Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 59. Sanofi Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 60. AstraZeneca Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 61. Alkem Laboratories Limited Revenue Growth Rate in Antiparasitic Drugs Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart